• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Deximune 25, 50, 100 mg
    / Dexcel


    Active Ingredient
    Cyclosporine 25, 50, 100 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Capsules

    50 x 25 mg

    full basket chart 10442 4024

    Capsules

    50 x 50 mg

    full basket chart 10443 4144

    Capsules

    50 x 100 mg

    full basket chart 10444 4039

    Related information


    Dosage

    For additional information, please contact the license holder.


    Indications

    Prophylaxis of organ rejection in kidney, liver, heart allogenic transplants in conjunction with corticosteroids. May also be used in the treatment of chronic  rejection in patients previously treated with other immuno-suppressive agents. Bone marrow transplantation. Endogenous uveitis. Severe psoriasis above age 16 that did not respond to other treatment. Atopic dermatitis in adults only up to 8 weeks, for severe cases in which conventional therapy is ineffective or inappropriate. Rheumatoid arthritis: Severe cases in which standard treatments are ineffective or inappropriate. Nephrotic syndrome type MCD (minimal change disease) in cases where conventional therapy has failed.


    Contra-Indications

    Breastfeeding. Hypersensitivity to one of the ingredients. Patients with atopic dermatitis or psoriasis who also suffer from impaired kidney function, unstable blood pressure, uncontrolled infections or any type of cancer, except certain skin tumors that require a biopsy prior to use of this medicine. Patients with rheumatoid arthritis who also suffer from impaired kidney function, unstable blood pressure, uncontrolled infections or any type of cancer, or in patients under 18 years of age. Concomitant administration of Deximun with the drugs tacrolimus or with rosuvastatin. Patients with nephrotic syndrome who also suffer from unstable blood pressure, uncontrolled infections or any type of cancer.


    Special Precautions

    For additional information, please contact the license holder.


    Side Effects

    For additional information, please contact the license holder.


    Drug interactions

    For additional information, please contact the license holder.


    Pregnancy and Lactation

    For additional information, please contact the license holder.


    Overdose

    For additional information, please contact the license holder.


    Manufacturer
    Dexcel Ltd.
    Licence holder
    CLOSE